Hyper-IL-6 gene therapy reverses fulminant hepatic failure

Molecular Therapy

Volumn 3, Issue 5, 2001, Pages 683-687

  Hecht, Naama ^a   Pappo, Orit ^a   Shouval, Daniel ^a   Rose John, Stefan ^b   Galun, Eithan ^a   Axelrod, Jonathan H ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

D galactosamine; Fulminant hepatic failure; Gene therapy; Gp130 hyperstimulation; Hyper IL 6; IL 6 sIL 6R

Indexed keywords

GALACTOSAMINE; INTERLEUKIN 6; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATALITY; GENE THERAPY; GENETIC CODE; LIVER FAILURE; LIVER FUNCTION; LIVER NECROSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; SURVIVAL;

ADENOVIRIDAE; ANIMALIA;

EID: 0034985726     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0313     Document Type: Article

References (21)

1. Fulminant hepatic failure: Summary of a workshop
2. Acute liver failure
3. Fulminant hepatic failure
4. Acute liver failure
5. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice
6. Liver regeneration
7. Interleukin-6 in biology and medicine
8. Interleukin-6 and soluble interleukin-6 receptor: Direct stimulation of gp130 and hematopoiesis
9. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
10. A bioactive designer cytokine for human hematopoietic progenitor cell expansion
11. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6
12. A simplified system for generating recombinant adenoviruses
13. Experimental hepatitis induced by d-galactosamine
14. Immunopathology of acute galactosamine hepatitis in rats
15. Glycine and uridine prevent d-galactosamine hepatotoxicity in the rat: Role of Kupffer cells
16. d-Galactosamine-induced mouse hepatic apoptosis: Possible involvement with tumor necrosis factor, but not with caspase-3 activity
17. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury
18. In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs
19. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo
20. Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period
21. Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers